Covered recipient · General Payments record
GEORGE J PAR
Allopathic & Osteopathic Physicians Ophthalmology Retina Specialist
General Payments · PY2018–2024
$115,247.28
- Reported across 144 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $482.20 | 14 |
| Education | $40.56 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $200.05 | 3 |
| Genentech USA, Inc. | $144.84 | 7 |
| Astellas Pharma Global Development | $70.44 | 1 |
| ABBVIE INC. | $42.23 | 2 |
| Regeneron Healthcare Solutions, Inc. | $40.56 | 2 |
| Sandoz Inc. | $24.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.91 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185526 | CMS |
| ABBVIE INC. | $19.32 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185528 | CMS |
| Astellas Pharma Global Development | $70.44 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132966407 | CMS |
| Biogen, Inc. | $63.26 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104875208 | CMS |
| Biogen, Inc. | $12.00 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104843808 | CMS |
| Biogen, Inc. | $124.79 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104864986 | CMS |
| Genentech USA, Inc. | $33.92 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133014366 | CMS |
| Genentech USA, Inc. | $30.57 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133014374 | CMS |
| Genentech USA, Inc. | $19.65 | 07/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133014370 | CMS |
| Genentech USA, Inc. | $33.07 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133014378 | CMS |
| Genentech USA, Inc. | $14.02 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133014382 | CMS |
| Genentech USA, Inc. | $8.66 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133014386 | CMS |
| Genentech USA, Inc. | $4.95 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133014390 | CMS |
| Regeneron Healthcare Solutions, Inc. | $20.73 | 07/11/2024 | Education | Undisputed | 01/23/2026 | 1114131283 | CMS |
| Regeneron Healthcare Solutions, Inc. | $19.83 | 07/11/2024 | Education | Undisputed | 01/23/2026 | 1114131285 | CMS |
| Sandoz Inc. | $24.64 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089363941 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.